MILLENNIUM MANAGEMENT LLC - 26 Jan 2026 SCHEDULE 13G Report for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN)

Filing manager: MILLENNIUM MANAGEMENT LLC
Reporting owner: Millennium Management LLC
Security: Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: SUPN
Shares outstanding: 57,285,340 shares
Disclosed shares: 3,036,123 shares
Disclosed ownership percentage: 5.3%
Form type: SCHEDULE 13G
Filing time: 02 Feb 2026, 16:33:37 UTC
Event date: 26 Jan 2026
Next filing: 18 Feb 2026
SEC filing: View on sec.gov

Key filing fact

MILLENNIUM MANAGEMENT LLC disclosed 5.3% ownership in Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN) on 26 Jan 2026.

Key facts

MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN).
Disclosed ownership: 5.3%.
Date of event: 26 Jan 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Millennium Management LLC	5.3%	3,036,123	3,036,123	/s/ Gil Raviv	Gil Raviv, Global General Counsel
Millennium Group Management LLC	5.3%	3,036,123	3,036,123	/s/ Gil Raviv	Gil Raviv, Global General Counsel
Israel A. Englander	5.3%	3,036,123	3,036,123	/s/ Israel A. Englander	Israel A. Englander

CIK / CUSIP context first

Broader feeds